Skip to content
AnalystLens

Omega Healthcare Investors 8-K Report, Executive Changes (Jan 2, 2024)

Reports
Leadership Changes·Exhibits & Filings
Filing Date
Filed January 2, 2024
Period End
January 1, 2024
Security
OHI
In the record · 2016–202610-K1210-Q348-K126

OHI filed 12 annual reports (10-K), 34 quarterly reports (10-Q) and 126 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · May ’17May ’17
  2. Material agreement8-K · Oct ’20Oct ’20
  3. Leadership change8-K · Jan ’23Jan ’23
  4. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 8-K filed January 2, 2024. Cited figures are marked; the original filing is the authoritative source.

Omega Healthcare Investors, Inc. (OHI) filed this Form 8-K on January 2, 2024 to report an amendment to the employment agreements of its named executive officers.

As of January 1, 2024, the Company entered into amendments with each named executive officer that extend the term of their employment agreements by one year, to December 31, 2026, and revise their annual base salaries following the annual review conducted by the Compensation Committee of the Board of Directors. The filing states that no other material amendments were made to these employment agreements. The report is limited to Item 5.02 (Departure of Directors or Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits).

The only listed exhibit is Exhibit 104, the Cover Page Interactive Data File embedded in the Inline XBRL document. The filing does not disclose the specific salary figures or the amounts of any compensation changes.

For investors, the filing signals management continuity, since the named executive officers' employment terms now run through December 31, 2026. The filing contains no information on financial results, operations, or other corporate developments.

Key Highlights

  1. Employment agreements with each named executive officer were amended as of January 1, 2024.
  2. The term of each agreement was extended by one year, to December 31, 2026.
  3. Annual base salaries were revised following the annual review by the Compensation Committee of the Board of Directors.
  4. The filing states that no other material amendments were made to the employment agreements.
  5. Item 5.02 (compensatory arrangements of certain officers) is the principal disclosure; the filing lists no other substantive items.
  6. The only listed exhibit is Exhibit 104, the Inline XBRL cover page data file.
  7. The report was signed by Gail D. Makode, Chief Legal Officer and General Counsel, on January 2, 2024.

Frequently Asked Questions

  1. What changed in the executives' employment agreements?

    The term of each named executive officer's employment agreement was extended by one year, to December 31, 2026, and annual base salaries were revised following the Compensation Committee's annual review. The filing states that no other material amendments were made.

  2. Which executives are affected?

    The filing refers to each of the Company's named executive officers but does not name them in this report.

  3. Does the filing disclose the new salary amounts?

    No. The filing states that base salaries were revised but does not list the revised amounts.

  4. Does this 8-K report financial results or other corporate events?

    No. The filing covers only the executive employment agreement amendments under Items 5.02 and 9.01 and includes no financial statements or results.

  5. Who signed the filing?

    Gail D. Makode, Chief Legal Officer and General Counsel, signed the report on behalf of Omega Healthcare Investors, Inc. on January 2, 2024.